Johnson Investment Counsel’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.08M | Sell |
2,802
-941
| -25% | -$349K | 0.01% | 450 |
|
|
2026
Q1 | $1.1M | Sell |
3,743
-805
| -18% | -$265K | 0.01% | 425 |
|
|
2025
Q4 | $1.59M | Sell |
4,548
-107
| -2% | -$36.2K | 0.01% | 348 |
|
|
2025
Q3 | $1.5M | Sell |
4,655
-721
| -13% | -$224K | 0.01% | 355 |
|
|
2025
Q2 | $2.09M | Sell |
5,376
-235
| -4% | -$94.5K | 0.02% | 300 |
|
|
2025
Q1 | $2.44M | Buy |
5,611
+126
| +2% | +$50.6K | 0.02% | 250 |
|
|
2024
Q4 | $2.02M | Sell |
5,485
-381
| -6% | -$159K | 0.02% | 282 |
|
|
2024
Q3 | $3.05M | Sell |
5,866
-1,342
| -19% | -$717K | 0.03% | 222 |
|
|
2024
Q2 | $3.91M | Buy |
7,208
+1,480
| +26% | +$782K | 0.04% | 174 |
|
|
2024
Q1 | $2.97M | Buy |
5,728
+937
| +20% | +$466K | 0.03% | 209 |
|
|
2023
Q4 | $2.26M | Buy |
4,791
+607
| +15% | +$281K | 0.03% | 236 |
|
|
2023
Q3 | $1.82M | Sell |
4,184
-16
| -0.4% | -$7.26K | 0.02% | 256 |
|
|
2023
Q2 | $1.87M | Sell |
4,200
-245
| -6% | -$113K | 0.02% | 259 |
|
|
2023
Q1 | $2.04M | Sell |
4,445
-149
| -3% | -$70.9K | 0.03% | 235 |
|
|
2022
Q4 | $2.36M | Buy |
4,594
+214
| +5% | +$109K | 0.03% | 214 |
|
|
2022
Q3 | $1.99M | Buy |
4,380
+315
| +8% | +$151K | 0.03% | 217 |
|
|
2022
Q2 | $1.96M | Buy |
4,065
+660
| +19% | +$327K | 0.03% | 224 |
|
|
2022
Q1 | $1.67M | Sell |
3,405
-5
| -0.1% | -$2.29K | 0.02% | 266 |
|
|
2021
Q4 | $1.58M | Buy |
3,410
+123
| +4% | +$51.7K | 0.02% | 275 |
|
|
2021
Q3 | $1.23M | Sell |
3,287
-482
| -13% | -$183K | 0.02% | 308 |
|
|
2021
Q2 | $1.44M | Sell |
3,769
-1,004
| -21% | -$384K | 0.02% | 266 |
|
|
2021
Q1 | $1.71M | Sell |
4,773
-725
| -13% | -$233K | 0.03% | 240 |
|
|
2020
Q4 | $1.76M | Sell |
5,498
-6
| -0.1% | -$1.84K | 0.03% | 213 |
|
|
2020
Q3 | $1.48M | Buy |
5,504
+44
| +0.8% | +$11.8K | 0.03% | 217 |
|
|
2020
Q2 | $1.44M | Sell |
5,460
-247
| -4% | -$65.9K | 0.03% | 215 |
|
|
2020
Q1 | $1.3M | Sell |
5,707
-199
| -3% | -$54.2K | 0.03% | 213 |
|
|
2019
Q4 | $1.78M | Sell |
5,906
-83
| -1% | -$22.8K | 0.03% | 214 |
|
|
2019
Q3 | $1.44M | Buy |
5,989
+7
| +0.1% | +$1.92K | 0.03% | 234 |
|
|
2019
Q2 | $1.69M | Buy |
5,982
+1,179
| +25% | +$322K | 0.03% | 218 |
|
|
2019
Q1 | $1.38M | Sell |
4,803
-183
| -4% | -$52.9K | 0.03% | 256 |
|
|
2018
Q4 | $1.31M | Sell |
4,986
-143
| -3% | -$39.3K | 0.03% | 246 |
|
|
2018
Q3 | $1.41M | Sell |
5,129
-703
| -12% | -$182K | 0.03% | 262 |
|
|
2018
Q2 | $1.39M | Buy |
5,832
+79
| +1% | +$18.3K | 0.03% | 243 |
|
|
2018
Q1 | $1.26M | Sell |
5,753
-170
| -3% | -$39.9K | 0.03% | 232 |
|
|
2017
Q4 | $1.33M | Sell |
5,923
-138
| -2% | -$29.4K | 0.03% | 226 |
|
|
2017
Q3 | $1.15M | Buy |
6,061
+121
| +2% | +$23K | 0.03% | 235 |
|
|
2017
Q2 | $1.12M | Buy |
5,940
+883
| +17% | +$159K | 0.03% | 237 |
|
|
2017
Q1 | $836K | Sell |
5,057
-11
| -0.2% | -$1.75K | 0.02% | 268 |
|
|
2016
Q4 | $728K | Buy |
5,068
+108
| +2% | +$14.5K | 0.02% | 289 |
|
|
2016
Q3 | $621K | Sell |
4,960
-175
| -3% | -$22.6K | 0.02% | 303 |
|
|
2016
Q2 | $674K | Sell |
5,135
-106
| -2% | -$14.5K | 0.02% | 280 |
|
|
2016
Q1 | $728K | Buy |
5,241
+1,512
| +41% | +$202K | 0.03% | 261 |
|
|
2015
Q4 | $519K | Buy |
3,729
+383
| +11% | +$52.8K | 0.02% | 317 |
|
|
2015
Q3 | $468K | Buy |
+3,346
| New | +$503K | 0.02% | 328 |
|
|
2014
Q4 | – | Sell |
-3,704
| Closed | -$443K | – | 565 |
|
|
2014
Q3 | $443K | Sell |
3,704
-99
| -3% | -$11.4K | 0.01% | 342 |
|
|
2014
Q2 | $409K | Sell |
3,803
-101
| -3% | -$10.4K | 0.01% | 335 |
|
|
2014
Q1 | $388K | Hold |
3,904
| – | – | 0.01% | 334 |
|
|
2013
Q4 | $360K | Sell |
3,904
-109
| -3% | -$9.69K | 0.01% | 353 |
|
|
2013
Q3 | $335K | Buy |
4,013
+1,056
| +36% | +$90.5K | 0.01% | 351 |
|
|
2013
Q2 | $242K | Buy |
+2,957
| New | +$221K | 0.01% | 447 |
|
Other funds holding ELV
Johnson Investment Counsel's ELV Position: Q2 2026 in Review
Johnson Investment Counsel reduced its Elevance Health (ELV) stake by 25% in Q2 2026, selling an estimated $349K and leaving 2,802 shares worth $1.08M. The position accounts for 0.01% of the portfolio, ranked #450.
Johnson Investment Counsel first reported a position in ELV in Q2 2013 and has held it in 50 quarters since. The position peaked at $3.91M in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Johnson Investment Counsel held 2,802 shares of Elevance Health worth $1.08M as of Q2 2026.
- Johnson Investment Counsel sold 941 Elevance Health shares in Q2 2026, an estimated $349K.
- Elevance Health made up 0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #450 holding.
- Johnson Investment Counsel first reported a position in Elevance Health in Q2 2013 and has held it in 50 quarters since.
- Johnson Investment Counsel's Elevance Health position peaked at $3.91M in Q2 2024.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.